Want to see IN:NH full AI Analyst Report?
NH Stock Chart & Stats
₹1756.45
₹14.10(1.04%)
At close: 4:00 PM EST
₹1756.45
₹14.10(1.04%)
Day’s Range― - ―
52-Week Range₹1,564.25 - ₹2,094.30
Previous CloseN/A
Volume860.19K
Average Volume (3M)80.08K
Market Cap
₹374.94B
Enterprise Value₹361.29K
Total Cash (Recent Filing)₹25.43B
Total Debt (Recent Filing)₹58.57B
Price to Earnings (P/E)46.1
Beta0.79
Next Earnings
Nov 11, 2026Next Dividend Ex-DateN/A
Dividend Yield0.24%
Share Statistics
EPS (TTM)39.63
Shares Outstanding204,360,800
10 Day Avg. Volume19,057
30 Day Avg. Volume80,081
Financial Highlights & Ratios
PEG Ratio19.78
Price to Book (P/B)7.32
Price to Sales (P/S)4.21
P/FCF Ratio55.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)54.88
Revenue Forecast (FY)₹108.37B
Bulls Say, Bears Say
Bulls Say
Accelerating Revenue GrowthSustained high revenue growth—from 12.1% to 31.8%—signals expanding patient volumes and improved case mix. Over a 2–6 month horizon this supports better utilization of hospital capacity, stronger operating leverage, and durable demand for tertiary services that underpins reinvestment decisions.
Improved Cash GenerationMaterial restoration of operating cash flow and a rebound to positive free cash flow improves internal funding for maintenance capex and working capital. This strengthens medium‑term self‑funding capacity, reduces immediate reliance on external financing and supports strategic investments or deleveraging.
Tertiary And Super‑specialty NetworkA nationwide network focused on tertiary/quaternary and cardiac care creates competitive differentiation through referral flows, specialist expertise and higher‑value procedures. This structural positioning supports more resilient revenue per case and referral stickiness over the medium term.
Bears Say
Sharp FY2026 Debt IncreaseThe large jump in debt materially raises leverage and interest burdens, reducing financial flexibility. Over months this heightens refinancing, covenant and liquidity risk if operating performance softens, limiting capacity to fund growth or absorb shocks without external support.
Volatile Free Cash Flow HistoryLarge year‑to‑year swings in free cash flow point to sensitivity to investment cycles and working capital. This volatility complicates cash forecasting and raises the risk that temporary cash shortfalls could coincide with higher debt service, constraining strategic flexibility.
Margin And Profitability VolatilityWhile profits recovered from earlier losses, margins have shown variability tied to case mix and cost cycles. Such margin swings reduce earnings predictability and increase exposure to reimbursement pressure, input cost inflation or adverse case‑mix shifts over the medium term.
Narayana Hrudayalaya Ltd. News
NH FAQ
What was Narayana Hrudayalaya Ltd.’s price range in the past 12 months?
Narayana Hrudayalaya Ltd. lowest stock price was ₹1564.25 and its highest was ₹2094.30 in the past 12 months.
What is Narayana Hrudayalaya Ltd.’s market cap?
Narayana Hrudayalaya Ltd.’s market cap is ₹374.94B.
When is Narayana Hrudayalaya Ltd.’s upcoming earnings report date?
Narayana Hrudayalaya Ltd.’s upcoming earnings report date is Nov 11, 2026 which is in 91 days.
How were Narayana Hrudayalaya Ltd.’s earnings last quarter?
Narayana Hrudayalaya Ltd. released its earnings results on Jul 31, 2026. The company reported ₹10.15 earnings per share for the quarter, missing the consensus estimate of ₹11.947 by -₹1.797.
Is Narayana Hrudayalaya Ltd. overvalued?
According to Wall Street analysts Narayana Hrudayalaya Ltd.’s price is currently Overvalued.
Does Narayana Hrudayalaya Ltd. pay dividends?
Narayana Hrudayalaya Ltd. pays a Annually dividend of ₹4.5 which represents an annual dividend yield of 0.24%. See more information on Narayana Hrudayalaya Ltd. dividends here
What is Narayana Hrudayalaya Ltd.’s EPS estimate?
Narayana Hrudayalaya Ltd.’s EPS estimate is 14.
How many shares outstanding does Narayana Hrudayalaya Ltd. have?
Narayana Hrudayalaya Ltd. has 204,360,800 shares outstanding.
What happened to Narayana Hrudayalaya Ltd.’s price movement after its last earnings report?
Narayana Hrudayalaya Ltd. reported an EPS of ₹10.15 in its last earnings report, missing expectations of ₹11.947. Following the earnings report the stock price went down -2.491%.
Which hedge fund is a major shareholder of Narayana Hrudayalaya Ltd.?
Currently, no hedge funds are holding shares in IN:NH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Narayana Hrudayalaya Ltd.
Narayana Hrudayalaya Limited, established in 2000 and headquartered in Bengaluru, India, operates as a prominent provider of medical and healthcare services. The company oversees and manages a diverse range of healthcare facilities, encompassing hospitals, clinics, health centers, and nursing homes. It delivers specialized care across a comprehensive spectrum of medical disciplines, including cardiology, cardiac surgery, nephrology, urology, neurology, neuro-surgery, endocrinology, orthopedics, internal medicine, obstetrics, gynecology, pediatrics, neonatology, gastroenterology, and oncology. As of June 30, 2022, Narayana Hrudayalaya maintained an extensive network that included 19 owned or operated hospitals, 2 managed hospitals, 4 heart centers, and 18 clinics and information centers throughout India, complemented by an international presence with one hospital in the Cayman Islands. Additionally, the company extends its expertise through healthcare consultancy services, which involve the licensing of its ERP solutions.
Technical Analysis
Apollo Hospitals Enterprise Limited
―
Aster DM Healthcare Ltd.
―
Fortis Healthcare Ltd.
―
Max Healthcare Institute Ltd
―
Global Health Limited
―